Topoisomerase II inhibitors, together with mitoxantrone, are related to the event of secondary acute myeloid leukemia and myelosuppression. People who experienced an incomplete antileukemic reaction acquired a 2nd induction training course through which mitoxantrone or daunorubicin was administered for 2 days and cytarabine for 5 times using the exact each https://euripidesd185vag9.atualblog.com/profile